21 – 30 of 155
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2023
- 
                        Mark
        ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Predictive biomarkers in radioresistant rectal cancer : A systematic review
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer : a long-term follow-up of the SweBCG91RT randomized trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        Evaluating patient reported outcomes and experiences in a novel proton beam clinic – challenges, activities, and outcomes of the ProtonCare project
    
    - Contribution to journal › Article
 
- 
                        Mark
        Combined anti-C1-INH and radiotherapy against glioblastoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        The Benefits and Harms of Pharmacological Treatment for Postradiation Pelvic Pain : A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel with Recommendations for Clinical Practice
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        GPR30 in breast cancer - from molecular mechanisms to clinical outcome
    (2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        Epidemiological and clinical aspects of T-cell lymphoma
    (2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
